Indeed, high expression of syntenin-1 in BC primary tumors has been significantly related to patient overall survival and progression-free survival (Yang et al., 2013b), and it is known to be negatively correlated to ER expression (Qian et al., 2013). The gene discussed is ESR1; the disease is breast cancer.